Welldoc Earns 2025 BIG Artificial Intelligence Excellence Award

Recognition Reinforces Welldoc’s Position as a Digital Health Leader Driving AI Innovation in Healthcare

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc^®, a digital health leader revolutionizing cardiometabolic care, today announced that it has been named a winner in the 2025 Artificial Intelligence Excellence Awards program presented by the Business Intelligence Group. The Artificial Intelligence Excellence Awards recognize groundbreaking advancements in AI and companies that have demonstrated a commitment to innovation and significant measurable impact.

Welldoc has been named an Artificial Intelligence Excellence Award winner in the Health Organization category for the AI powering its digital health platform. The platform empowers individuals with personalized, AI-driven digital coaching to enable self-management of cardiometabolic conditions, positive lifestyle changes and improved overall health and outcomes. The scalable, cost-effective, multi-condition platform holistically supports complex combinations of some of the most prevalent cardiometabolic conditions, including prediabetes, diabetes, hypertension, heart failure and weight management, including GLP-1 and obesity medication support.

Welldoc continues to advance its AI with even more precise personalization by integrating technology like real-time sensors. The company’s latest AI excels by correlating insights across a broad spectrum of health data, surpassing the capabilities of other solutions. Welldoc’s dynamic, adaptive AI models, powered by evidence-based guidelines and proprietary large sensor models, translate complex numerical data into personalized insights and coaching, while also maintaining clinical integrity and adhering to AI-specific regulatory guidelines.

"Welldoc is committed to driving meaningful AI innovation in healthcare," said Anand Iyer, PhD, MBA, Chief AI Officer of Welldoc. "This award validates the important work we are doing to build more sophisticated personalization and help individuals improve their health.”

With more than 50 newly issued AI patents, complementing its 11 diabetes Federal Drug Administration (FDA) 510(k) Class II clearances, Welldoc is uniquely positioned to lead next-generation digital health and continue forging strong partnerships with life science and device leaders to develop innovative combination solutions in cardiometabolic health, prescription drug use-related software (PDURS) and software in a medical device (SiMD).

"The AI industry is evolving rapidly, and it is through the efforts of companies like Welldoc that we see real-world applications driving change," said Russ Fordyce, CEO of the Business Intelligence Group. "Welldoc’s work exemplifies the kind of innovation and leadership that is shaping the future of artificial intelligence."

About Welldoc
Welldoc^®, a digital health leader revolutionizing cardiometabolic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with cardiometabolic conditions, enabling improved health and outcomes. Welldoc’s comprehensive digital health platform provides AI-powered digital coaching across pre-diabetes, diabetes, hypertension, heart failure and weight and obesity management, with integrated mental wellbeing and sleep support. Welldoc is an FDA-cleared digital health solution that guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. The company partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs.

Welldoc has achieved 11 510(k) clearances for diabetes functionality within its digital health platform, and an IP portfolio of 50+ patents for its advanced AI and first-in-class tech. With over 90 clinical publications, Welldoc has also built an extensive library of clinical research, including many publications focused on the value of combining CGM with AI-powered digital health solutions. Welldoc is an industry thought leader and has been showcased in prestigious conferences and publications, including South by Southwest, The Wall Street Journal and The Economist. The company has been named the “Best Overall Digital Health Company” by MedTech Breakthrough for the past two years and was selected as a winner of the 2025 AI Excellence Awards by Business Intelligence Group, 2024 Healthcare AI Impact Awards, Innovation Awards by Business Intelligence Group and Top 100 Healthcare Technology Companies by the Healthcare Technology Report. For more information, visit www.welldoc.com. Follow us on LinkedIn and X.

About Business Intelligence Group
The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization's proprietary and unique scoring system selectively measures performance across multiple business domains and rewards those companies whose achievements stand above those of their peers. Visit www.bintelligence.com.